• Optimizing Mammalian Gene Expression: ARCA EGFP mRNA in Assa

  2026-06-18

  Discover how ARCA EGFP mRNA empowers direct, quantitative assessment of mammalian cell gene expression. This article uniquely explores advanced protocol parameters, mRNA stability strategies, and translational assay design for fluorescence-based applications.

• NSD1-Driven PPARγ Methylation Suppresses Glycolysis in EC

  2026-06-18

  This study identifies NSD1-mediated monomethylation of PPARγ at lysine 98 as a critical regulator of PTEN expression and glycolysis in endometrial cancer (EC). By elucidating this epigenetic-metabolic axis, the research opens new avenues for targeting metabolic vulnerabilities in NSD1-deficient EC tumors.

• Indole-3-pyruvic Acid: Applied Workflows for Plant & Immune

  2026-06-17

  Indole-3-pyruvic acid (IPA) is a versatile metabolic intermediate that empowers both plant hormone biosynthesis research and advanced immunomodulation studies. This article delivers actionable workflows, troubleshooting strategies, and critical insights from recent breakthroughs, equipping researchers to optimize IPA-based experiments for maximum reliability.

• nor-NOHA Acetate: Applied Arginase Inhibition in Cancer Rese

  2026-06-17

  nor-NOHA (acetate) empowers researchers to dissect arginine metabolism, enhance nitric oxide signaling, and model apoptosis and cell migration in cancer and vascular biology. This guide distills experimental workflows, translational insights, and troubleshooting strategies to maximize reproducibility and impact using APExBIO's high-purity nor-NOHA acetate.

• Indole Analogue Tc3 as a Pyroptosis Inducer in Hepatic Carci

  2026-06-16

  The reference study introduces Tc3, an indole-based small molecule that potently induces pyroptosis in hepatic carcinoma via gasdermin E activation and ROS upregulation. This work provides a mechanistic rationale for combining Tc3 with cisplatin or anti-PD-1 immunotherapy, offering new avenues for overcoming resistance in liver cancer treatment.

• Biotin-HPDP: Redefining Thiol-Specific Labeling in Translati

  2026-06-16

  Explore how Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) is revolutionizing thiol-specific protein biotinylation for translational research. This article blends mechanistic insight, strategic protocol guidance, and expert analysis on the competitive landscape with actionable recommendations for detecting S-nitrosylated proteins and advancing affinity purification workflows. Grounded in recent innovations and illustrated by emerging immunotherapy breakthroughs, discover how this reagent—offered by APExBIO—empowers researchers to tackle the complexity of dynamic protein modifications and set new standards in redox biology.

• SP2509: Potent Lysine-Specific Demethylase 1 Antagonist in A

  2026-06-15

  SP2509 redefines acute myeloid leukemia research as a next-generation LSD1 antagonist, driving precise epigenetic modulation, apoptosis, and differentiation. This article delivers actionable workflows, in-depth troubleshooting, and strategic context for leveraging SP2509 in advanced cancer epigenetics.

• Calpain Inhibitor I, ALLN: Technical Parameters and Workflow

  2026-06-15

  Calpain Inhibitor I, ALLN is a selective inhibitor of calpain and cathepsin proteases, supporting precision in apoptosis assays and ischemia-reperfusion injury models. It is best used where selective control of cysteine protease activity is required. This compound is unsuitable for diagnostic or clinical applications and should not be used where water solubility is essential.

• Taltirelin Acetate: Strategic Mechanisms for Translational N

  2026-06-14

  Taltirelin acetate, a long-acting TRH analog, is redefining neuropharmaceutical research through its precision receptor targeting, robust neuroprotective actions, and unique translational versatility. This article provides mechanistic insights, protocol guidance, and strategic considerations for researchers leveraging Taltirelin in models of Parkinson’s disease, chronic itch, and obstructive sleep apnea, while highlighting regulatory pathways and competitive positioning within the BCS biowaiver framework. Differentiating itself from standard product pages, this piece integrates the latest evidence, practical protocols, and forward-looking analysis to empower translational teams.

• Cimetidine: Distinct H2 Antagonist for Cancer & BBB Research

  2026-06-13

  Cimetidine is a histamine-2 receptor antagonist with a unique partial agonist profile, offering distinct advantages in both gastrointestinal cancer research and advanced blood-brain barrier (BBB) modeling. Its high solubility and rigorously verified purity make it a preferred tool for bench and translational workflows.

• Direct Mouse Genotyping Kit: Accelerate PCR from Mouse Tissu

  2026-06-12

  The Direct Mouse Genotyping Kit transforms mouse genetic screening by enabling rapid PCR amplification without DNA purification. With streamlined workflows and robust results, this APExBIO solution is ideal for high-throughput genotyping in biomedical research.

• DHHC9-STRN4 Palmitoylation Modulates YAP-Driven Cancer Metas

  2026-06-12

  The reference study uncovers DHHC9-mediated palmitoylation of STRN4 as a pivotal driver of YAP-dependent cancer metastasis, highlighting a novel regulatory axis in adenocarcinoma. By pharmacologically targeting this modification, the work reveals actionable insights into metastatic suppression and provides a framework for future drug discovery targeting post-translational modifications.

• VE-821 ATR Kinase Inhibitor: Reliable DDR Assays & Workflow

  2026-06-11

  This article delivers scenario-driven, evidence-based guidance for biomedical researchers using VE-821 (SKU A2521) as an ATR kinase inhibitor in DNA repair pathway research and radiosensitization assays. By addressing real laboratory challenges—from protocol optimization to product selection—the piece demonstrates how VE-821’s selectivity, potency, and compatibility with standard workflows underpin reproducible results.

• Mianserin HCl in 5-HT2 Antagonist Research: Protocols & Adva

  2026-06-11

  Mianserin HCl’s selective 5-HT2 receptor antagonism and unique inclusion complex chemistry unlock advanced experimental workflows in psychiatric and antipathogenic research. This article details evidence-backed protocols, troubleshooting strategies, and translational innovations, empowering researchers to maximize reproducibility and impact using APExBIO’s validated compound.

• ARCA EGFP mRNA (5-moUTP): Precision Control for mRNA Transfe

  2026-06-10

  ARCA EGFP mRNA (5-moUTP) delivers unrivaled transfection control and direct fluorescence-based detection, leveraging ARCA capping and 5-methoxyuridine for superior protein expression and immune evasion. This advanced, polyadenylated mRNA sets a new benchmark for reproducibility, troubleshooting, and workflow optimization in mammalian cell experiments.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page